Botanix Pharmaceuticals Limited

ASX (AUD): Botanix Pharmaceuticals Limited (BOT)

Last Price

0.455

Today's Change

-0.02 (4.21%)

Day's Change

0.435 - 0.48

Trading Volume

20,325,202

Overview

Market Cap

830 Million

Shares Outstanding

1 Billion

Avg Volume

5,221,194

Avg Price (50 Days)

0.38

Avg Price (200 Days)

0.34

PE Ratio

-45.50

EPS

-0.01

Earnings Announcement

26-Feb-2025

Previous Close

0.47

Open

0.47

Day's Range

0.435 - 0.48

Year Range

0.1625 - 0.505

Trading Volume

20,325,202

Price Change Highlight

1 Day Change

-4.21%

5 Day Change

-1.09%

1 Month Change

22.97%

3 Month Change

26.39%

6 Month Change

19.74%

Ytd Change

1.11%

1 Year Change

139.47%

3 Year Change

490.91%

5 Year Change

369.07%

10 Year Change

1850.03%

Max Change

-99.62%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment